Effect of leuprolide acetate on ovarian function after cyclophosphamide-doxorubicin-based chemotherapy in premenopausal patients with breast cancer: results from a phase II randomized trial.
about
Chemotherapy- and irradiation-induced bone loss in adults with solid tumorsROR1 expression correlated with poor clinical outcome in human ovarian cancerOvarian suppression using luteinizing hormone-releasing hormone agonists during chemotherapy to preserve ovarian function and fertility of breast cancer patients: a meta-analysis of randomized studies.Utility of gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage in premenopausal women with breast cancer: a systematic review and meta-analysis.Protecting Effects of Gonadotropin-Releasing Hormone Agonist on Chemotherapy-Induced Ovarian Damage in Premenopausal Breast Cancer Patients: A Systematic Review and Meta-Analysis.Gonadotropin-Releasing Hormone Agonists for Ovarian Function Preservation in Premenopausal Women Undergoing Chemotherapy for Early-Stage Breast Cancer: A Systematic Review and Meta-analysis.Factors associated with ovarian function recovery after chemotherapy for breast cancer: a systematic review and meta-analysis.Cancer and fertility preservation: international recommendations from an expert meeting.Gonadotropin-releasing hormone agonists for ovarian protection during cancer chemotherapy: systematic review and meta-analysis.Sequential versus simultaneous use of chemotherapy and gonadotropin-releasing hormone agonist (GnRHa) among estrogen receptor (ER)-positive premenopausal breast cancer patients: effects on ovarian function, disease-free survival, and overall survivaPreservation of gonadal function in women undergoing chemotherapy: a systematic review and meta-analysis of the potential role for gonadotropin-releasing hormone agonists.
P2860
Q28084019-274852AC-485A-4382-BB24-139AF711779BQ33942010-31492EFE-9969-449B-9838-70C0AC2D1146Q35766397-DE01F709-3CC6-484D-9678-BC8C81BEC0B7Q35856600-FB369B5E-8107-4F89-ACDC-2CBB85BCC9C4Q36404774-4D975C3D-17F1-4B2C-9170-0022D99191C9Q37213101-83E81C15-008E-4A92-9231-356F7B5D9CCCQ38963455-702ACF0B-623C-4BE7-912E-74ACB74D4F11Q43106184-3D5A9411-28C6-4BDD-BCA6-05E0A6A9562EQ46144166-FA1EF09C-480D-44CB-8138-4D98454FB95CQ48248647-FB29314F-013B-43F3-9E81-7636030248FEQ53272116-3AF393EC-F648-431E-9852-AE4A44B0E43B
P2860
Effect of leuprolide acetate on ovarian function after cyclophosphamide-doxorubicin-based chemotherapy in premenopausal patients with breast cancer: results from a phase II randomized trial.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Effect of leuprolide acetate o ...... m a phase II randomized trial.
@en
Effect of leuprolide acetate o ...... m a phase II randomized trial.
@nl
type
label
Effect of leuprolide acetate o ...... m a phase II randomized trial.
@en
Effect of leuprolide acetate o ...... m a phase II randomized trial.
@nl
prefLabel
Effect of leuprolide acetate o ...... m a phase II randomized trial.
@en
Effect of leuprolide acetate o ...... m a phase II randomized trial.
@nl
P2093
P2860
P1433
P1476
Effect of leuprolide acetate o ...... m a phase II randomized trial.
@en
P2093
Guiping Song
Zhixiang Yuan
P2860
P2888
P356
10.1007/S12032-013-0667-8
P577
2013-08-01T00:00:00Z